Binu John MD MPH, FACG, FAASLD
Hepatology & Liver Transplantation
Chief of Gastroenterology and Hepatology, Miami VA Medical Center, Miami FL Associate Professor, University of Miami Miller School of Medicine
Join to View Full Profile
1201 16th St nwMiami, FL 33125
Phone+1 305-575-7000
Dr. John is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Binu John is an Associate Professor, University of Miami Miller School of Medicine and the Chief of Gastroenterology and Hepatology at the Miami VA Health System. He is a federally funded researcher with VA Merit, society and investigator initiated grants funding and has over 300 abstracts and peer reviewed publications in cirrhosis, portal hypertension, PBC, and hepatocellular carcinoma.
Education & Training
Cleveland Clinic FoundationFellowship, Gastroenterology, 2007 - 2010- Cleveland Clinic FoundationResidency, Internal Medicine, 2005 - 2007
Christian Medical College VelloreClass of 1998
Certifications & Licensure
FL State Medical License 2013 - 2027
VA State Medical License 2016 - 2022
OH State Medical License 2005 - 2018
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction-associated steatotic liver disease.Binu V John, Dustin R Bastaich, Yangyang Deng, Amit G Singal, Bassam Dahman
Hepatology. 2025-08-14 - 3 citationsValidation and Epidemiologic Definition of the Novel Steatotic Liver Disease Nomenclature in a National United States Cohort With Cirrhosis.Catherine Mezzacappa, Pedro Ochoa-Allemant, Marina Serper, Tamar H Taddei, Binu V John
Clinical Gastroenterology and Hepatology. 2025-08-01 - Association of Glucagon-Like Peptide-1 Receptor Agonists With Liver-Related Outcomes and All-Cause Mortality in Patients With Harmful Alcohol Use: A Target Trial Emula...Binu V John, Dustin Bastaich, Daniella Marchetti, Ponni Perumalswami, Mixael Zirio Mustafa
The American Journal of Gastroenterology. 2025-06-10
Press Mentions
Third COVID-19 Vaccine Dose Reduces Infection, Critical Disease Risk in Cirrhosis by 80%November 7th, 2022- Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis PatientsOctober 26th, 2022
- Miller School Faculty Front and Center at DDW ’22June 28th, 2022
- Join now to see all
Grant Support
- Addition of F18-Piflufolastat PET/CT to Cross-Sectional Imaging for the Staging and Management of Hepatocellular CarcinomaMIAMI VA HEALTH CARE SYSTEM2024–2028
Committees
- Clinical practice update committee, American Gastroenterology Association 2025 - Present
- Research Awards Committee, American Gastroenterology Association 2025 - Present
- Annual education committee, American Association of the study of liver diseases 2025 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
